Hw. Hopp et al., A synergistic approach to optimal stenting - Directional coronary atherectomy prior to coronary artery stent implantation - The AtheroLink registry, J AM COL C, 36(6), 2000, pp. 1853-1859
Citations number
19
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES The AtheroLink registry sought to observe the effect of plaque b
urden reduction by directional coronary atherectomy (DCA) prior to stenting
on acute lesion success rate, on the clinical success rate and on the inci
dence of in-stent restenosis six months after intervention.
BACKGROUND Although coronary stenting has reduced restenosis, its effect ha
s been less favorable in complex lesions with a high plaque burden that res
ults from suboptimal stent expansion. Therefore, plaque removal by DCA may
improve the results of coronary stenting.
METHODS A total of 167 patients with >60% stenosis in a native coronary art
ery of 2.8 to 4.0 mm in diameter were enrolled in 10 study centers on an in
tention-to-treat basis. All patients underwent DCA aimed at an optimal resu
lt (residual diameter stenosis <20%) followed by stenting. Angiographic fol
low-up was performed in 120 (71.8%) patients at 5.3 +/- 2.8 months.
RESULTS Lesion success was achieved in 164/167 (98.2%) patients, and the cl
inical success rate was 95.2% (159/167 patients). The overall restenosis ra
te in the 120 patients with angiographic follow-up nas 10.8% (13/120). inci
dence of restenosis was lower (8.4%) in patients with optimal stent deploym
ent following DCA compared to patients with a persisting caliber reduction
>15% (restenosis rate 15.3.%) and restenosis occurred with a significantly
higher frequency (p < 0.04) in distal lesions (37.5%) compared to proximal
stenoses (9.0%).
CONCLUSIONS This observational multicenter registry points to a potential r
eduction in restenosis by a synergistic approach of DCA and stenting perfor
med under routinely accessible angiographic guidance. Therefore, multicente
r-based randomized clinical trials are clearly warranted to finally clarify
the validity of this complex approach versus conventional angioplasty plus
stenting. (C) 2000 by the American College of Cardiology.